[Multidrug resistance tuberculosis - current problems].

Abstract

The rising occurrence of multidrug-resistant tuberculosis (MDR-TB), defined as resistance to at least isoniazid and rifampicin, is a serious worldwide problem. The treatment of MDR-TB with alternative chemotherapy is difficult due to side-effects and treatment duration. It is also very expensive and sometimes unsuccessful. DOTS and DOTS-Plus strategy are necessary to achieve a good tuberculosis control.

Cite this paper

@article{Kruczak2009MultidrugRT, title={[Multidrug resistance tuberculosis - current problems].}, author={Katarzyna Kruczak and Ewa Nizankowska-Mogilnicka}, journal={Pneumonologia i alergologia polska}, year={2009}, volume={77 3}, pages={276-83} }